{"HCI":[{"Model ID":"HCI HCI-001",
"Patient ID":"HCI Y0ACP5",
"Gender":"Female",
"Age":"40",
"Ethnicity":"caucasian",
"Clinical Diagnosis":"breast cancer",
"Primary Site":"Breast",
"Consent":"yes",
"Sample Site":"Breast",
"Tumor Type":"Primary",
"Sample Type":"surgical sample",
"Histology":"Invasive Ductal Carcinoma",
"Grades":"3; Nottingham",
"Stage":"Stage IV",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"no",
"Strain":"NOD/SCID and NSG (Jax)",
"Tumor Prep":"solid",
"Engraftment Site":"cleared mammary fat pad",
"Mouse Treatment":"",
"Engraftment Rate":"80-100%",
"QA":"histology; IHC",
"QA Passage":"multiple",
"Platform":"exome; RNAseq; CNV; RPPA",
"Strain Metastatis":"Lung",
"Doubling Time":"NOD.SCID: 2 months to 1cm",
"Distributing":"yes",
"Additional Info":"PMC3553601",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI HCI-002",
"Patient ID":"HCI 0RR2HE",
"Gender":"Female",
"Age":"61",
"Ethnicity":"caucasian",
"Clinical Diagnosis":"breast cancer",
"Primary Site":"Breast",
"Consent":"yes",
"Sample Site":"Breast",
"Tumor Type":"Primary",
"Sample Type":"surgical sample",
"Histology":"Invasive Ductal Carcinoma",
"Grades":"3; Nottingham",
"Stage":"Stage IIIA",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"yes",
"Strain":"NOD/SCID and NSG (Jax)",
"Tumor Prep":"solid",
"Engraftment Site":"cleared mammary fat pad",
"Mouse Treatment":"",
"Engraftment Rate":"80-100%",
"QA":"histology; IHC",
"QA Passage":"multiple",
"Platform":"exome; RNAseq; CNV; RPPA",
"Strain Metastatis":"Lung; LN",
"Doubling Time":"NOD.SCID: 1 month to 1cm",
"Distributing":"yes",
"Additional Info":"PMC3553601",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI HCI-003",
"Patient ID":"HCI 3BW6YS",
"Gender":"Female",
"Age":"52",
"Ethnicity":"caucasian",
"Clinical Diagnosis":"breast cancer",
"Primary Site":"Breast",
"Consent":"yes",
"Sample Site":"Breast",
"Tumor Type":"Primary",
"Sample Type":"surgical sample",
"Histology":"Invasive Ductal Carcinoma",
"Grades":"3; Nottingham",
"Stage":"Stage IIIA",
"Markers":"ER positive; PR positive; HER2 negative",
"Treatment Naive":"yes",
"Strain":"NOD/SCID and NSG (Jax)",
"Tumor Prep":"solid",
"Engraftment Site":"cleared mammary fat pad",
"Mouse Treatment":"0.5 mg estrogen pellet",
"Engraftment Rate":"80-100%",
"QA":"histology; IHC",
"QA Passage":"multiple",
"Platform":"exome; RNAseq; CNV; RPPA",
"Strain Metastatis":"Lung; LN",
"Doubling Time":"NOD.SCID: 4 months to 1cm",
"Distributing":"yes",
"Additional Info":"PMC3553601",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI HCI-004",
"Patient ID":"HCI N12K3Y",
"Gender":"Female",
"Age":"55",
"Ethnicity":"Hispanic",
"Clinical Diagnosis":"breast cancer",
"Primary Site":"Breast",
"Consent":"yes",
"Sample Site":"Breast",
"Tumor Type":"Primary",
"Sample Type":"surgical sample",
"Histology":"Invasive Ductal Carcinoma",
"Grades":"3; Nottingham",
"Stage":"Stage IIA",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"yes",
"Strain":"NOD/SCID and NSG (Jax)",
"Tumor Prep":"solid",
"Engraftment Site":"cleared mammary fat pad",
"Mouse Treatment":"",
"Engraftment Rate":"80-100%",
"QA":"histology; IHC",
"QA Passage":"multiple",
"Platform":"exome; RNAseq; CNV; RPPA",
"Strain Metastatis":"not found",
"Doubling Time":"NOD.SCID: 4 months to 1cm; NSG: 5 months to 2cm",
"Distributing":"yes",
"Additional Info":"PMC3553601",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI HCI-005",
"Patient ID":"HCI 79NTL6",
"Gender":"Female",
"Age":"45",
"Ethnicity":"caucasian",
"Clinical Diagnosis":"breast cancer",
"Primary Site":"Breast",
"Consent":"yes",
"Sample Site":"Pleural Effusion fluid",
"Tumor Type":"Metastatic",
"Sample Type":"Pleural Effusion fluid",
"Histology":"Mixed multi-centric disease - IDC and DCIS",
"Grades":"N/A",
"Stage":"Stage IV",
"Markers":"ER positive; PR positive; HER2 positive",
"Treatment Naive":"no",
"Strain":"NOD/SCID and NSG (Jax)",
"Tumor Prep":"suspension in matrigel",
"Engraftment Site":"cleared mammary fat pad",
"Mouse Treatment":"0.5 mg estrogen pellet",
"Engraftment Rate":"80-100%",
"QA":"histology; IHC",
"QA Passage":"multiple",
"Platform":"exome; RNAseq; CNV; RPPA",
"Strain Metastatis":"Lung; LN;  peritoneum",
"Doubling Time":"NOD.SCID: 5 months to 1cm",
"Distributing":"yes",
"Additional Info":"PMC3553601",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI HCI-006",
"Patient ID":"HCI 79NTL6",
"Gender":"Female",
"Age":"45",
"Ethnicity":"caucasian",
"Clinical Diagnosis":"breast cancer",
"Primary Site":"Breast",
"Consent":"yes",
"Sample Site":"Pleural Effusion fluid",
"Tumor Type":"Metastatic",
"Sample Type":"Pleural Effusion fluid",
"Histology":"",
"Grades":"N/A",
"Stage":"Stage IV",
"Markers":"ER positive; PR positive; HER2 positive",
"Treatment Naive":"no",
"Strain":"NOD/SCID and NSG (Jax)",
"Tumor Prep":"suspension in matrigel",
"Engraftment Site":"cleared mammary fat pad",
"Mouse Treatment":"0.5 mg estrogen pellet",
"Engraftment Rate":"80-100%",
"QA":"histology; IHC",
"QA Passage":"multiple",
"Platform":"exome; RNAseq; CNV; RPPA",
"Strain Metastatis":"Lung; LN;  peritoneum",
"Doubling Time":"NOD.SCID: 6 months to 1cm",
"Distributing":"yes",
"Additional Info":"PMC3553601",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI HCI-007",
"Patient ID":"HCI 79NTL6",
"Gender":"Female",
"Age":"45",
"Ethnicity":"caucasian",
"Clinical Diagnosis":"breast cancer",
"Primary Site":"Breast",
"Consent":"yes",
"Sample Site":"Pleural Effusion fluid",
"Tumor Type":"Metastatic",
"Sample Type":"Pleural Effusion fluid",
"Histology":"",
"Grades":"N/A",
"Stage":"Stage IV",
"Markers":"ER positive; PR positive; HER2 positive",
"Treatment Naive":"no",
"Strain":"NOD/SCID and NSG (Jax)",
"Tumor Prep":"suspension in matrigel",
"Engraftment Site":"cleared mammary fat pad",
"Mouse Treatment":"0.5 mg estrogen pellet",
"Engraftment Rate":"80-100%",
"QA":"histology; IHC",
"QA Passage":"multiple",
"Platform":"exome; RNAseq; CNV; RPPA",
"Strain Metastatis":"Lung; LN; bone",
"Doubling Time":"NOD.SCID: 4 months to 1cm",
"Distributing":"yes",
"Additional Info":"PMC3553601",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI HCI-008",
"Patient ID":"HCI 24PSK3",
"Gender":"Female",
"Age":"85",
"Ethnicity":"caucasian",
"Clinical Diagnosis":"breast cancer",
"Primary Site":"Breast",
"Consent":"yes",
"Sample Site":"Pleural Effusion fluid",
"Tumor Type":"Metastatic",
"Sample Type":"Pleural Effusion fluid",
"Histology":"inflammatory breast cancer",
"Grades":"N/A",
"Stage":"Stage IV",
"Markers":"ER negative; PR negative; HER2 positive",
"Treatment Naive":"no",
"Strain":"NOD/SCID and NSG (Jax)",
"Tumor Prep":"suspension in matrigel",
"Engraftment Site":"cleared mammary fat pad",
"Mouse Treatment":"",
"Engraftment Rate":"0.5",
"QA":"histology; IHC",
"QA Passage":"multiple",
"Platform":"exome; RNAseq; CNV; RPPA",
"Strain Metastatis":"Lung; LN",
"Doubling Time":"NOD.SCID: 5 months  to 5mm; NSG 7 months to 2cm",
"Distributing":"no",
"Additional Info":"PMC3553601",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI HCI-009",
"Patient ID":"HCI 779812",
"Gender":"Female",
"Age":"42",
"Ethnicity":"caucasian",
"Clinical Diagnosis":"breast cancer",
"Primary Site":"Breast",
"Consent":"yes",
"Sample Site":"Ascites fluid",
"Tumor Type":"Metastatic",
"Sample Type":"Ascites fluid",
"Histology":"adenocarcinoma",
"Grades":"N/A",
"Stage":"Stage IV",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"no",
"Strain":"NOD/SCID and NSG (Jax)",
"Tumor Prep":"suspension in matrigel",
"Engraftment Site":"cleared mammary fat pad",
"Mouse Treatment":"",
"Engraftment Rate":"80-100%",
"QA":"histology; IHC",
"QA Passage":"multiple",
"Platform":"exome; RNAseq; CNV; RPPA",
"Strain Metastatis":"Lung; LN; peritoneum",
"Doubling Time":"NOD.SCID: 4 months to 2cm",
"Distributing":"yes",
"Additional Info":"PMC3553601",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI HCI-010",
"Patient ID":"HCI SUCWJ9",
"Gender":"Female",
"Age":"47",
"Ethnicity":"caucasian",
"Clinical Diagnosis":"breast cancer",
"Primary Site":"Breast",
"Consent":"yes",
"Sample Site":"Pleural Effusion fluid",
"Tumor Type":"Metastatic",
"Sample Type":"Pleural Effusion fluid",
"Histology":"Invasive Ductal Carcinoma",
"Grades":"N/A",
"Stage":"Stage IV",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"no",
"Strain":"NOD/SCID and NSG (Jax)",
"Tumor Prep":"suspension in matrigel",
"Engraftment Site":"cleared mammary fat pad",
"Mouse Treatment":"",
"Engraftment Rate":"80-100%",
"QA":"histology; IHC",
"QA Passage":"multiple",
"Platform":"exome; RNAseq; CNV; RPPA",
"Strain Metastatis":"Lung; LN",
"Doubling Time":"NOD.SCID: 4 months to 2cm",
"Distributing":"yes",
"Additional Info":"PMC3553601",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI HCI-011",
"Patient ID":"HCI Y0T0JD",
"Gender":"Female",
"Age":"58",
"Ethnicity":"Hispanic",
"Clinical Diagnosis":"breast cancer",
"Primary Site":"Breast",
"Consent":"yes",
"Sample Site":"Pleural Effusion fluid",
"Tumor Type":"Metastatic",
"Sample Type":"Pleural Effusion fluid",
"Histology":"Invasive Ductal Carcinoma",
"Grades":"N/A",
"Stage":"Stage IV",
"Markers":"ER positive; PR positive; HER2 negative",
"Treatment Naive":"no",
"Strain":"NOD/SCID and NSG (Jax)",
"Tumor Prep":"suspension in matrigel",
"Engraftment Site":"cleared mammary fat pad",
"Mouse Treatment":"0.5 mg estrogen pellet",
"Engraftment Rate":"80-100%",
"QA":"histology; IHC",
"QA Passage":"multiple",
"Platform":"exome; RNAseq; CNV; RPPA",
"Strain Metastatis":"Lung; LN",
"Doubling Time":"NOD.SCID: 4 months to 1cm",
"Distributing":"yes",
"Additional Info":"PMC3553601",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI HCI-012",
"Patient ID":"HCI 2SF730",
"Gender":"Female",
"Age":"49",
"Ethnicity":"caucasian",
"Clinical Diagnosis":"breast cancer",
"Primary Site":"Breast",
"Consent":"yes",
"Sample Site":"Pleural Effusion fluid",
"Tumor Type":"Metastatic",
"Sample Type":"Pleural Effusion fluid",
"Histology":"Invasive Ductal Carcinoma",
"Grades":"N/A",
"Stage":"Stage IV",
"Markers":"ER negative; PR negative; HER2 positive",
"Treatment Naive":"no",
"Strain":"NOD/SCID and NSG (Jax)",
"Tumor Prep":"suspension in matrigel",
"Engraftment Site":"cleared mammary fat pad",
"Mouse Treatment":"",
"Engraftment Rate":"80-100%",
"QA":"histology; IHC",
"QA Passage":"multiple",
"Platform":"exome; RNAseq; CNV; RPPA",
"Strain Metastatis":"LN; thyumus",
"Doubling Time":"NOD.SCID: 4 months to 1cm; NSG: 4 months to 2cm",
"Distributing":"yes",
"Additional Info":"PMC3553601",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI HCI-013",
"Patient ID":"HCI B6WNCG",
"Gender":"Female",
"Age":"46",
"Ethnicity":"caucasian",
"Clinical Diagnosis":"breast cancer",
"Primary Site":"Breast",
"Consent":"yes",
"Sample Site":"Pleural Effusion fluid",
"Tumor Type":"Metastatic",
"Sample Type":"Pleural Effusion fluid",
"Histology":"Invasive Lobular Carcinoma",
"Grades":"N/A",
"Stage":"Stage IV",
"Markers":"ER positive; PR positive; HER2 negative",
"Treatment Naive":"no",
"Strain":"NOD/SCID and NSG (Jax)",
"Tumor Prep":"suspension in matrigel",
"Engraftment Site":"cleared mammary fat pad",
"Mouse Treatment":"0.5 mg estrogen pellet",
"Engraftment Rate":"80-100%",
"QA":"histology; IHC",
"QA Passage":"multiple",
"Platform":"exome; RNAseq; RPPA",
"Strain Metastatis":"in progress",
"Doubling Time":"NOD.SCID: 4 months to 2cm",
"Distributing":"yes",
"Additional Info":"PMC3955299",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI HCI-013EI",
"Patient ID":"HCI B6WNCG",
"Gender":"Female",
"Age":"46",
"Ethnicity":"caucasian",
"Clinical Diagnosis":"breast cancer",
"Primary Site":"Breast",
"Consent":"yes",
"Sample Site":"Pleural Effusion fluid",
"Tumor Type":"Metastatic",
"Sample Type":"HCI-013 PDX tumor",
"Histology":"Invasive Lobular Carcinoma",
"Grades":"N/A",
"Stage":"Stage IV",
"Markers":"ER positive; PR positive; HER2 negative",
"Treatment Naive":"no",
"Strain":"NOD/SCID and NSG (Jax)",
"Tumor Prep":"solid PDX chunk",
"Engraftment Site":"cleared mammary fat pad",
"Mouse Treatment":"ovariectomized",
"Engraftment Rate":"80-100%",
"QA":"histology; IHC",
"QA Passage":"multiple",
"Platform":"targeted seq",
"Strain Metastatis":"in progress",
"Doubling Time":"NOD.SCID: 3 months to 2cm",
"Distributing":"yes",
"Additional Info":"PMC3955299",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI HCI-015",
"Patient ID":"HCI FENPV8",
"Gender":"Female",
"Age":"49",
"Ethnicity":"caucasian",
"Clinical Diagnosis":"breast cancer",
"Primary Site":"Breast",
"Consent":"yes",
"Sample Site":"Brain",
"Tumor Type":"Metastatic",
"Sample Type":"surgical sample",
"Histology":"Invasive Ductal Carcinoma",
"Grades":"N/A",
"Stage":"Stage IV",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"no",
"Strain":"NOD/SCID and NSG (Jax)",
"Tumor Prep":"solid",
"Engraftment Site":"cleared mammary fat pad",
"Mouse Treatment":"",
"Engraftment Rate":"80-100%",
"QA":"histology; IHC",
"QA Passage":"multiple",
"Platform":"exome; RNAseq; RPPA",
"Strain Metastatis":"in progress",
"Doubling Time":"NOD.SCID: 5 months to 1cm; NSG: 3 months to 1cm",
"Distributing":"yes",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI HCI-016",
"Patient ID":"HCI AG8G17",
"Gender":"Female",
"Age":"90+",
"Ethnicity":"caucasian",
"Clinical Diagnosis":"breast cancer",
"Primary Site":"Breast",
"Consent":"yes",
"Sample Site":"Breast",
"Tumor Type":"Primary",
"Sample Type":"surgical sample",
"Histology":"Invasive Ductal Carcinoma",
"Grades":"3; Nottingham",
"Stage":"unknown",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"unknown",
"Strain":"NOD/SCID and NSG (Jax)",
"Tumor Prep":"solid",
"Engraftment Site":"cleared mammary fat pad",
"Mouse Treatment":"",
"Engraftment Rate":"80-100%",
"QA":"histology; IHC",
"QA Passage":"multiple",
"Platform":"exome; RNAseq; RPPA",
"Strain Metastatis":"in progress",
"Doubling Time":"NOD.SCID: 7+ months to 1cm; NSG: 4 months to 1cm",
"Distributing":"yes",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI HCI-017",
"Patient ID":"HCI G04XZJ",
"Gender":"Female",
"Age":"53",
"Ethnicity":"caucasian",
"Clinical Diagnosis":"breast cancer",
"Primary Site":"Breast",
"Consent":"yes",
"Sample Site":"Breast",
"Tumor Type":"Primary",
"Sample Type":"biopsy",
"Histology":"Invasive Ductal Carcinoma",
"Grades":"3; Nottingham",
"Stage":"Stage IV",
"Markers":"ER positive; PR positivie; HER2 negative",
"Treatment Naive":"yes",
"Strain":"NOD/SCID and NSG (Jax)",
"Tumor Prep":"solid",
"Engraftment Site":"cleared mammary fat pad",
"Mouse Treatment":"0.5 mg estrogen pellet",
"Engraftment Rate":"80-100%",
"QA":"histology; IHC",
"QA Passage":"multiple",
"Platform":"exome; RNAseq; RPPA",
"Strain Metastatis":"in progress",
"Doubling Time":"NOD.SCID: 4 months to 1cm",
"Distributing":"yes",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI HCI-019",
"Patient ID":"HCI 4XF05M",
"Gender":"Female",
"Age":"59",
"Ethnicity":"Hispanic",
"Clinical Diagnosis":"breast cancer",
"Primary Site":"Breast",
"Consent":"yes",
"Sample Site":"Breast",
"Tumor Type":"Primary",
"Sample Type":"surgical sample",
"Histology":"Invasive Ductal Carcinoma",
"Grades":"3; Nottingham",
"Stage":"",
"Markers":"ER negative (1%); PR negative; HER2 negative",
"Treatment Naive":"no",
"Strain":"NOD/SCID and NSG (Jax)",
"Tumor Prep":"solid",
"Engraftment Site":"cleared mammary fat pad",
"Mouse Treatment":"",
"Engraftment Rate":"80-100%",
"QA":"histology; IHC",
"QA Passage":"multiple",
"Platform":"exome; RNAseq; RPPA",
"Strain Metastatis":"Lung",
"Doubling Time":"NSG: 2 months to 1cm",
"Distributing":"yes",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-0002",
"Patient ID":"HCI 24452-40",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Black or African American",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Metastatic",
"Sample Type":"Excision",
"Histology":"Adenocarcinoma; metastatic; NOS",
"Grades":"",
"Stage":"",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-0046",
"Patient ID":"HCI 2219-20",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Excision",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"T2",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"Unknown",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"Estradiol Water",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-0104",
"Patient ID":"HCI 24561-20",
"Gender":"Female ",
"Age":"",
"Ethnicity":"White",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Excision",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"T4b",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"No",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"Estradiol Water",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-0132",
"Patient ID":"HCI 28918-20",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Black or African American; Not Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Biopsy",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-2147",
"Patient ID":"HCI 24455-25",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Black or African American",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Biopsy",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"No Estrogen Added",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-2277",
"Patient ID":"HCI 24455-30",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Black or African American",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Excision",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"T3",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"Unknown",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"No Estrogen Added",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-2665",
"Patient ID":"HCI 24457-50",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Excision",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"T2",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"Unknown",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-3107",
"Patient ID":"HCI 24459-120",
"Gender":"Female ",
"Age":"",
"Ethnicity":"White; Not Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Excision",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"",
"Stage":"",
"Markers":"ER negative; PR negative",
"Treatment Naive":"No",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-3143",
"Patient ID":"HCI 24458-25",
"Gender":"Female ",
"Age":"",
"Ethnicity":"White",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Biopsy",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"",
"Markers":"ER negative; PR negative; HER2 positive",
"Treatment Naive":"",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-3204",
"Patient ID":"HCI 24460-20",
"Gender":"Female ",
"Age":"",
"Ethnicity":"White",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Biopsy",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"",
"Stage":"",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"Unknown",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-3472",
"Patient ID":"HCI 24458-30",
"Gender":"Female ",
"Age":"",
"Ethnicity":"White",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Excision",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"T2",
"Markers":"ER negative; PR negative; HER2 positive",
"Treatment Naive":"No",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-3887",
"Patient ID":"HCI 24469-50",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Black or African American; Not Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Recurrent",
"Sample Type":"Biopsy",
"Histology":"Intraductal carcinoma; noninfiltrating; NOS",
"Grades":"G2 (Moderately Differentiated)",
"Stage":"",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-3904",
"Patient ID":"HCI 24470-20",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Biopsy",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-3936",
"Patient ID":"HCI 24471-20",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Excision",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"T2",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-3963",
"Patient ID":"HCI 666-15",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Biopsy",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"",
"Markers":"ER negative; PR negative; HER2 positive",
"Treatment Naive":"",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-4013",
"Patient ID":"HCI 24473-25",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Black or African American",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Not Specified",
"Sample Type":"Biopsy",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"",
"Stage":"",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"",
"Strain":"NSG",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-4169",
"Patient ID":"HCI 666-35",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Biopsy",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"T2",
"Markers":"ER negative; PR negative; HER2 positive",
"Treatment Naive":"",
"Strain":"NSG",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-4175",
"Patient ID":"HCI 24468-20",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Excision",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"T2",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"",
"Strain":"NSG",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-4189",
"Patient ID":"HCI 30224-25",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Recurrent",
"Sample Type":"Biopsy",
"Histology":"Lobular carcinoma in situ; NOS",
"Grades":"",
"Stage":"",
"Markers":"ER positive; PR negative",
"Treatment Naive":"",
"Strain":"SCID / bg",
"Tumor Prep":"Ascites cells",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-4195",
"Patient ID":"HCI 24476-20",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Excision",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"T3",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"Unknown",
"Strain":"NSG",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-4272",
"Patient ID":"HCI 24477-30",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Biopsy",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"",
"Stage":"",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-4664",
"Patient ID":"HCI 24480-20",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Black or African American; Not Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Excision",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"T3",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"No",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-4849",
"Patient ID":"HCI 24477-40",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Excision",
"Histology":"Metaplastic carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"T4b",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"No",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-4888",
"Patient ID":"HCI 24482-30",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Excision",
"Histology":"Intraductal micropapillary carcinoma",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"T3",
"Markers":"ER positive; PR positive; HER2 positive",
"Treatment Naive":"No",
"Strain":"NSG",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-5097",
"Patient ID":"HCI 24484-20",
"Gender":"Female ",
"Age":"",
"Ethnicity":"White",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Biopsy",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"",
"Markers":"ER positive; PR positive; HER2 negative",
"Treatment Naive":"",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-5156",
"Patient ID":"HCI 24485-20",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Excision",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"T3",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"No",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-5438",
"Patient ID":"HCI 24483-30",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Black or African American",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Excision",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"T4",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"No",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-5471",
"Patient ID":"HCI 24487-20",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Excision",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"T2",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"No",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-6257",
"Patient ID":"HCI 2804-20",
"Gender":"Female ",
"Age":"",
"Ethnicity":"White; Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Biopsy",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"",
"Stage":"",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-7482",
"Patient ID":"HCI 946-20",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Black or African American; Not Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Excision",
"Histology":"Metaplastic carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"T2",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"Yes",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-7649",
"Patient ID":"HCI 1366-20",
"Gender":"Female ",
"Age":"",
"Ethnicity":"White; Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Biopsy",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"",
"Stage":"",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"Silastic Tube",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-7821",
"Patient ID":"HCI 24560-20",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Black or African American",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Excision",
"Histology":"Infiltrating duct carcinoma; NOS",
"Grades":"G3 (Poorly Differentiated)",
"Stage":"T1c",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"No",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"Silastic Tube",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"},
{"Model ID":"HCI BCM-8563",
"Patient ID":"HCI 2279-20",
"Gender":"Female ",
"Age":"",
"Ethnicity":"Hispanic or Latino",
"Clinical Diagnosis":"Breast Cancer",
"Primary Site":"Breast",
"Consent":"",
"Sample Site":"",
"Tumor Type":"Primary",
"Sample Type":"Biopsy",
"Histology":"Intraductal carcinoma; noninfiltrating; NOS",
"Grades":"",
"Stage":"",
"Markers":"ER negative; PR negative; HER2 negative",
"Treatment Naive":"",
"Strain":"SCID / bg",
"Tumor Prep":"Tissue Fragment",
"Engraftment Site":"Orthotopic; mammary gland",
"Mouse Treatment":"0.36 E2 pellet",
"Engraftment Rate":"",
"QA":"",
"QA Passage":"",
"Platform":"",
"Strain Metastatis":"",
"Doubling Time":"",
"Distributing":"",
"Additional Info":"",
"Institution":"Huntsman Cancer Institute (PDXNet)"}]}